AQR Arbitrage’s Allergan plc AGN.PRA Stock Holding History

AQR Arbitrage’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-59,750	Closed	-$35.1M	–	456
2017 Q4	$35.1M	Hold	59,750	–	–	0.41%	53
2017 Q3	$43.8M	Buy	+59,750	New	+$49.6M	0.47%	52
2016 Q4	–	Sell	-214,250	Closed	-$175M	–	374
2016 Q3	$175M	Buy	214,250 +13,850	+7%	+$12M	1.72%	11
2016 Q2	$167M	Buy	+200,400	New	+$167M	1.81%	9
2016 Q1	–	Sell	-204,750	Closed	-$211M	–	459
2015 Q4	$211M	Buy	204,750 +16,400	+9%	+$16.5M	2.36%	4
2015 Q3	$178M	Buy	+188,350	New	+$196M	2.15%	5

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

AQR Arbitrage's AGN.PRA Position: Q1 2018 in Review

AQR Arbitrage sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 59,750 shares — an estimated $35.1M sold.

AQR Arbitrage first reported a position in AGN.PRA in Q3 2015 and held it in 6 quarters. The position peaked at $211M in Q4 2015. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

AQR Arbitrage reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
AQR Arbitrage sold 59,750 Allergan plc shares in Q1 2018, an estimated $35.1M.
AQR Arbitrage first reported a position in Allergan plc in Q3 2015 and held it in 6 quarters.
AQR Arbitrage's Allergan plc position peaked at $211M in Q4 2015.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on AQR Arbitrage's 13F filing for Q1 2018, filed 15 May 2018.